Loading clinical trials...
Loading clinical trials...
Effect of Dapagliflozin at Discharge on Hospital Re-Admissions in Patients With Acutely Decompensated Heart Failure: A Randomized Controlled Study
Conditions
Interventions
Dapagliflozin
Placebo
Locations
3
United States
Emory University Hospital
Atlanta, Georgia, United States
Tulane University
New Orleans, Louisiana, United States
Temple University
Philadelphia, Pennsylvania, United States
Start Date
July 29, 2020
Primary Completion Date
March 3, 2022
Completion Date
March 3, 2022
Last Updated
June 14, 2024
NCT07037459
NCT01399385
NCT06513026
NCT06874556
NCT06815081
NCT06807190
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions